GO:0032039 integrator complex: Components, Assembly and Research Methods

The integrator complex (GO:0032039) is a multi-subunit protein assembly that localizes to the nucleus and plays a critical role in RNA processing. It stably associates with the C-terminal domain of RNA polymerase II and is required for the 3'-end processing of small nuclear RNAs (snRNAs) generated by RNA polymerase II. This function places the integrator complex at the heart of snRNA maturation, which is essential for spliceosome assembly and proper gene expression. Researchers studying RNA biology, transcription, and cancer have increasingly focused on the integrator complex due to its broad impact on cellular homeostasis. Recent structural and functional studies have begun to reveal the molecular architecture of the integrator complex, including its subunit composition and assembly pathways. The complex comprises multiple subunits, termed INTS1 through INTS14, which form distinct modules that coordinate substrate recognition and catalysis. Beyond its canonical role in snRNA processing, emerging evidence links integrator complex subunits to the regulation of protein-coding gene expression and to disease states such as gastric cancer, where subunit expression correlates with patient prognosis and immune cell infiltration. Given its essential functions, the integrator complex represents a promising area for both basic and translational research. Understanding how its subunits assemble and function can provide insights into RNA processing mechanisms and reveal new opportunities for therapeutic intervention.

The integrator complex is a protein complex that stably associates with the C-terminus of RNA polymerase II and mediates 3'-end processing of small nuclear RNAs generated by RNA polymerase II.

The integrator complex is essential for the maturation of small nuclear RNAs, which are core components of the spliceosome. Without proper 3'-end processing by the integrator complex, snRNA levels are disrupted, leading to defects in pre-mRNA splicing and widespread changes in gene expression. Moreover, recent studies have highlighted that integrator complex subunits are differentially expressed in cancers and can influence tumor progression and immune responses, underscoring their clinical relevance.

The integrator complex comprises multiple subunits encoded by distinct genes, each contributing to the assembly and function of the complex.

The integrator complex is regulated through its association with RNA polymerase II and interactions with transcription factors, which influence its recruitment to target genes and its processing activity. Additionally, subunit expression levels can vary across tissues and disease states, suggesting transcriptional and post-transcriptional regulation.

Comprehensive analysis of integrator complex subunits in gastric cancer has revealed that their expression patterns are associated with prognosis and the tumor microenvironment. Specific subunits may serve as biomarkers or therapeutic targets.

Given its essential role in snRNA 3'-end processing, disruption of the integrator complex could lead to defects in splicing and RNA processing, which are hallmarks of certain developmental and neurological disorders.

The dependency of cancer cells on proper RNA processing suggests that integrator complex subunits could be explored as targets for anticancer therapy.

Cryo-electron microscopy and X-ray crystallography have been used to determine the architecture of the integrator complex and its subunits, providing insights into assembly and function.

RNA sequencing and ChIP-seq can assess changes in snRNA levels and gene expression upon perturbation of integrator complex subunits.

Affinity purification coupled with mass spectrometry can identify interacting partners and subunit stoichiometry of the integrator complex.

Pooled CRISPR knockout screens can systematically evaluate the requirement for each integrator complex subunit in cell growth and RNA processing.

Researchers studying integrator complex-related genes often need to determine whether a candidate gene is causally involved in RNA processing, cancer progression, or other biological processes. EDITGENE provides a comprehensive suite of CRISPR-based services to enable precise genetic perturbations and functional studies of integrator complex subunits.

The integrator complex (GO:0032039) is a central player in RNA processing, specifically in the 3'-end maturation of small nuclear RNAs. Its stable association with RNA polymerase II and its multi-subunit architecture underscore its importance in gene expression and cellular homeostasis. Emerging evidence links integrator complex subunits to cancer prognosis and tumor microenvironment, highlighting their potential as therapeutic targets. Continued research using advanced CRISPR models and structural approaches will further illuminate the complex's roles in health and disease.